OCULAR SCIENCES INC (OCLR) [Rocket]

In millions, except per share items	Dec-31-03	Dec-31-02	Dec-31-01	Dec-31-00	Dec-31-99
	10-K	10-K	10-K	10-K	10-K
Revenues	310.6	267.1	225.0	156.6	176.7
Revenue growth	16.3%	18.7%	43.7%	-11.4%
Cost of goods sold	143.4	120.3	97.8	72.9	63.4
Gross profit	167.2	146.8	127.2	83.6	113.3
Gross margin	53.8%	55.0%	56.5%	53.4%	64.1%
Selling, general and administrative [+]	115.6	97.6	78.7	46.7	64.6
Sales and marketing	86.0	72.9	53.8	25.7	44.9
General and administrative	29.6	24.7	24.9	21.0	19.7
Research and development	6.1	4.9	7.1	4.1	2.9
Other operating expenses			25.6
EBITDA [+]	70.7	65.6	35.4	45.2	54.3
EBITDA growth	7.8%	85.4%	-21.7%	-16.8%
EBITDA margin	22.8%	24.5%	15.7%	28.9%	30.7%
Depreciation and amortization	25.3	21.3	19.5	12.4	8.5
EBIT [+]	45.4	44.2	15.8	32.8	45.7
EBIT growth	2.6%	179.4%	-51.8%	-28.3%
EBIT margin	14.6%	16.6%	7.0%	21.0%	25.9%
Non-recurring items	10.9	34.5	4.2
Interest income, net [+]	0.0	-0.4	0.4	2.8	2.1
Interest expense	0.6	0.8	0.4	0.6	0.3
Interest income	0.6	0.4	0.9	3.4	2.4
Other income (expense), net	1.9	3.5	-0.3	20.5	-0.1
Pre-tax income	36.4	12.9	11.8	56.1	47.8
Income taxes	9.8	5.7	5.2	17.2	11.3
Tax rate	27.0%	44.1%	44.5%	30.6%	23.8%
Net income	26.6	7.2	6.5	38.9	36.4
Net margin	8.6%	2.7%	2.9%	24.9%	20.6%

Basic EPS [+]	$1.11	$0.31	$0.28	$1.68	$1.60
Growth	263.7%	9.4%	-83.4%	5.3%
Diluted EPS [+]	$1.11	$0.31	$0.28	$1.68	$1.60
Growth	263.7%	9.4%	-83.4%	5.3%

Shares outstanding (basic) [+]	23.9	23.6	23.4	23.2	22.8
Growth	1.2%	1.1%	1.0%	1.5%
Shares outstanding (diluted) [+]	23.9	23.6	23.4	23.2	22.8
Growth	1.2%	1.1%	1.0%	1.5%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.